SCHEMBL710848

SCHEMBL710848

Sc1ccc(I)cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18151 0.72
SCHEMBL10834459 0.71
SCHEMBL4390590 0.71 CCR1 (0.46)
SCHEMBL31243289 0.71
SCHEMBL198094 0.71
Iodide SCHEMBL10484675 0.69 NOS3 (0.46)
Iodide SCHEMBL10484569 0.69 NOS3 (0.46)
SCHEMBL12301380 0.67
SCHEMBL21573141 0.67
Iodide SCHEMBL8361370 0.67 NOS3 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112289937-B Quantum dot light-emitting diode and preparation method thereof TCL科技集团股份有限公司 2022-08-23 CN claimed
CN-112289937-A Quantum dot light-emitting diode and preparation method thereof TCL集团股份有限公司 2021-01-29 CN claimed
CN-112289937-B Quantum dot light-emitting diode and preparation method thereof TCL科技集团股份有限公司 2022-08-23 CN disclosed
US-11322750-B2 Surface modified platinum or platinum alloy catalyst for oxygen reduction reaction TOYOTA MOTOR ENGINEERING & MANUFACTURING NORTH AMERICA, INC. (US) 2022-05-03 US disclosed
CN-112289937-A Quantum dot light-emitting diode and preparation method thereof TCL集团股份有限公司 2021-01-29 CN disclosed
US-20200343562-A1 SURFACE MODIFIED PLATINUM OR PLATINUM ALLOY CATALYST FOR OXYGEN REDUCTION REACTION TOYOTA MOTOR ENGINEERING & MANUFACTURING NORTH AMERICA, INC. (US) 2020-10-29 US disclosed
US-8124610-B2 Sodium channel inhibitors ICAGEN INC. (US) 2012-02-28 US disclosed
US-8124610-B2 Sodium channel inhibitors ICAGEN INC. (US) 2012-02-28 US disclosed
US-8124610-B2 Sodium channel inhibitors ICAGEN INC. (US) 2012-02-28 US disclosed
EP-2173743-A2 SODIUM CHANNEL INHIBITORS Icagen, Inc. (US) 2010-04-14 EP disclosed
US-20090023740-A1 SODIUM CHANNEL INHIBITORS ICAGEN (US) 2009-01-22 US disclosed
US-20090023740-A1 SODIUM CHANNEL INHIBITORS ICAGEN (US) 2009-01-22 US disclosed
US-20090023740-A1 SODIUM CHANNEL INHIBITORS ICAGEN (US) 2009-01-22 US disclosed
WO-2009012242-A2 SODIUM CHANNEL INHIBITORS ICAGEN, INC. (US) 2009-01-22 WO disclosed
WO-2009012242-A2 SODIUM CHANNEL INHIBITORS ICAGEN, INC. (US) 2009-01-22 WO disclosed
US-3969526-A Anthelmintic 5-heterocycliothio and oxy-2-carbalkoxyaminobenzimidazles SMITHKLINE CORPORATION (US) 1976-07-13 US disclosed